Adenosine Deaminase (ADA) testing on pericardial fluid, integrated within the Helthesh system, is a diagnostic procedure used to assess potential causes of pericarditis, an inflammation of the pericardium (the sac surrounding the heart). Elevated ADA levels in pericardial fluid can indicate certain infectious or inflammatory conditions, such as tuberculosis or autoimmune diseases.

This test is particularly useful when tuberculosis is suspected, as elevated ADA levels in pericardial fluid are often seen in tuberculous pericarditis. The presence of tuberculosis in the pericardium can lead to a significant increase in ADA levels due to the immune response triggered by the infection.

ADA testing on pericardial fluid is typically performed using laboratory techniques to measure ADA activity levels. Results are then interpreted by healthcare professionals in conjunction with other clinical findings to guide diagnosis and treatment decisions.

Overall, Adenosine Deaminase testing on pericardial fluid, integrated within the Helthesh system, serves as an important tool in the evaluation of pericardial diseases, helping to identify underlying causes and guide appropriate management strategies.